GO:0098912 membrane depolarization during atrial cardiac muscle cell action potential: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098912 describes the rapid rise in atrial cardiac muscle cell membrane potential from the negative resting potential toward the action potential peak [1, 8].
• The upstroke is driven primarily by voltage-gated sodium channel (NaV1.5, SCN5A) current, with contributions from calcium and other ion channels [6, 8].
• Atrial-specific ion channel expression, including differences in repolarizing currents, shapes the depolarization phase and is remodeled in atrial fibrillation [1, 8].
• Human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCMs) provide a translational platform to study atrial depolarization and electrical remodeling [1, 5].
• Dysregulation of atrial depolarization contributes to arrhythmogenesis, including atrial fibrillation and other supraventricular tachycardias [1, 3, 8].
• CRISPR-based knockout, point mutation, and knock-in models enable causal testing of genes influencing atrial action potential upstroke [1, 5, 6].
Description
GO:0098912, membrane depolarization during atrial cardiac muscle cell action potential, is a biological process term that defines the phase in which the membrane potential of an atrial cardiac muscle cell rapidly shifts from its negative resting value toward the positive peak of the action potential [1, 8]. This depolarization phase is the electrical trigger for atrial contraction and is a critical determinant of impulse conduction and rhythm stability in the atria [2, 8]. Because atrial cardiomyocytes exhibit distinct ion channel expression profiles compared with ventricular cells, the mechanisms underlying atrial depolarization are not simply a mirror of ventricular electrophysiology [1, 8]. Understanding this process is essential for researchers investigating atrial arrhythmias, particularly atrial fibrillation, where electrical remodeling alters action potential morphology and depolarization kinetics [1, 8]. The term is also relevant to drug development, as many antiarrhythmic strategies aim to modulate the upstroke of the atrial action potential [1, 3]. In this article, we synthesize the current understanding of atrial depolarization based on published literature, highlighting the molecular players, regulatory mechanisms, disease associations, and experimental models used to study this process.
membrane depolarization during atrial cardiac muscle cell action potential At A Glance
| GO ID | GO:0098912 |
|---|---|
| GO term | membrane depolarization during atrial cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | atrial cardiac muscle cell depolarization; atrial depolarization; electrocardiogram PR interval |
| Major function | Rapid membrane potential change from resting to peak action potential in atrial cardiomyocytes |
| Primary ion channels | Voltage-gated sodium channels (e.g., NaV1.5/SCN5A), L-type calcium channels (CACNA1C), and others [6, 8] |
| Key regulatory context | Modulated by autonomic tone, electrolytes, and electrical remodeling in disease [1, 3, 8] |
| Disease relevance | Atrial fibrillation, supraventricular arrhythmias, and mechano-electric feedback disorders [1, 3, 8] |
| Research models | hiPSC-derived atrial cardiomyocytes, animal models, heterologous expression systems [1, 5] |
What Is GO:0098912?
GO:0098912 refers to the process in which the membrane potential of an atrial cardiac muscle cell changes in the depolarizing direction, moving from the negative resting potential toward the positive membrane potential that will be the peak of the action potential [1, 8]. This definition encompasses the rapid upstroke phase of the atrial action potential, which is primarily mediated by the influx of sodium ions through voltage-gated sodium channels, although other ion fluxes contribute [6, 8]. The term is a subprocess of the broader atrial cardiac muscle cell action potential and is distinguished from depolarization in other cardiac cell types by its specific occurrence in atrial myocytes [1, 8].
Why Is membrane depolarization during atrial cardiac muscle cell action potential Important in Cell Biology?
GO:0098912 is important because the depolarization phase of the atrial action potential determines the initiation and propagation of electrical impulses that govern atrial contraction and heart rhythm [2, 8]. Abnormalities in this process can lead to atrial arrhythmias, including atrial fibrillation, which is the most common sustained cardiac arrhythmia and a major cause of stroke and heart failure [1, 8]. Moreover, atrial-specific ion channel properties make this process a target for developing safer antiarrhythmic drugs with fewer ventricular side effects [1, 3]. Studying GO:0098912 also provides insight into how electrical remodeling in disease alters atrial excitability and contributes to arrhythmia maintenance [1, 8].
• Defines the electrical trigger for atrial contraction and coordinated heart function [2, 8].
• Dysregulation contributes to atrial fibrillation and other supraventricular arrhythmias [1, 8].
• Atrial-specific ion channel composition offers therapeutic selectivity for antiarrhythmic drugs [1, 3].
• Electrical remodeling in heart failure and atrial fibrillation alters depolarization kinetics [1, 8].
• Mechano-electric feedback can modulate atrial depolarization and arrhythmia susceptibility.
• Provides a target for gene editing to study causal roles of ion channel variants [1, 5, 6].
• Relevant to understanding sex differences and age-related changes in atrial electrophysiology [1, 8].
• Guides development of hiPSC-based disease models for precision medicine [1, 5].
What Happens During membrane depolarization during atrial cardiac muscle cell action potential?
Initiation of the upstroke: sodium channel activation
In simple terms: The atrial cell membrane suddenly becomes permeable to sodium ions, which rush in and make the inside more positive.
The depolarization phase begins when voltage-gated sodium channels, primarily NaV1.5 encoded by SCN5A, open in response to a threshold stimulus [6, 8]. This opening allows a rapid influx of sodium ions, causing the membrane potential to rise quickly from approximately -80 mV toward positive values [6, 8]. The distribution and availability of NaV1.5 channels at the intercalated disc and lateral membrane are critical for efficient depolarization. In atrial cardiomyocytes, the sodium current density and kinetics shape the upstroke velocity and conduction velocity.
Contribution of calcium channels to the later phase
In simple terms: As sodium channels begin to close, calcium channels open and help sustain the depolarization, bridging to the plateau phase.
Following the initial sodium-driven upstroke, L-type calcium channels (CACNA1C) activate and contribute to the later part of depolarization and the subsequent plateau [2, 8]. In atrial cells, T-type calcium channels may also play a role in early depolarization, although their contribution varies by species and disease state. The interplay between sodium and calcium currents determines the action potential duration and the effective refractory period, which are essential for normal atrial function [2, 8].
Role of potassium currents in shaping depolarization
In simple terms: Potassium channels open later to help end the depolarization and reset the cell, but some also influence the early phase.
Although potassium currents primarily drive repolarization, certain potassium channels, such as the transient outward current (Ito) and the ultra-rapid delayed rectifier (IKur), are active during early phases and can modulate the depolarization trajectory. In atrial fibrillation, remodeling of these currents, including reduced IKur and altered Ito, contributes to action potential changes that affect depolarization [1, 8]. The balance between inward and outward currents during the upstroke is crucial for the stability of the depolarization process.
Modulation by mechano-electric feedback
In simple terms: Stretching of the atrial muscle can change the electrical behavior of the cells, affecting how they depolarize.
Mechano-electric feedback refers to the modulation of cardiac electrical activity by mechanical stretch, which can influence ion channel gating and thereby alter depolarization. In the atria, stretch-activated channels and cytoskeletal interactions can change the resting potential and upstroke velocity, contributing to arrhythmogenesis under conditions of atrial dilation. This feedback loop is particularly relevant in atrial fibrillation, where atrial stretch is common.
Key Genes Involved in GO:0098912 membrane depolarization during atrial cardiac muscle cell action potential
The following genes encode ion channels, transporters, and regulatory proteins that are directly involved in or modulate membrane depolarization during atrial cardiac muscle cell action potential.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Encodes NaV1.5, the primary voltage-gated sodium channel mediating the rapid upstroke | Mutations cause Brugada syndrome, long QT syndrome, and atrial fibrillation; target for gene editing [6, 8] |
| CACNA1C | Encodes the alpha-1C subunit of L-type calcium channels contributing to later depolarization | Variants linked to Timothy syndrome and Brugada syndrome; modulates action potential plateau [2, 8] |
| CACNA1D | Encodes a T-type calcium channel subunit possibly involved in early depolarization | Investigated for roles in atrial arrhythmias and automaticity |
| KCNA5 | Encodes Kv1.5, underlying ultra-rapid delayed rectifier potassium current (IKur) | Atrial-specific; remodeling in atrial fibrillation affects depolarization and repolarization [1, 8] |
| KCND3 | Encodes Kv4.3, contributing to transient outward potassium current (Ito) | Modulates early repolarization and action potential shape; implicated in atrial fibrillation |
| KCNQ1 | Encodes Kv7.1, underlying slow delayed rectifier current (IKs) | Mutations cause long QT syndrome; influences action potential duration |
| KCNH2 | Encodes hERG, underlying rapid delayed rectifier current (IKr) | Mutations cause long QT syndrome; drug target for arrhythmias |
| SCN1B | Encodes beta-1 subunit of sodium channels, modulating NaV1.5 gating | Mutations linked to Brugada syndrome and atrial fibrillation |
| SCN2B | Encodes beta-2 subunit of sodium channels, affecting channel trafficking and gating | Modulates sodium current density; potential modifier of atrial excitability |
| ATP1A1 | Encodes Na+/K+-ATPase alpha-1 subunit, maintaining resting potential | Dysfunction alters resting potential and indirectly affects depolarization |
| ATP2A2 | Encodes SERCA2a, regulating calcium handling and indirectly influencing depolarization | Variants linked to Darier disease and cardiac dysfunction |
| RYR2 | Encodes ryanodine receptor 2, mediating calcium release from sarcoplasmic reticulum | Mutations cause catecholaminergic polymorphic ventricular tachycardia; affects atrial calcium handling |
| GJA1 | Encodes connexin 43, forming gap junctions for electrical coupling | Modulates conduction velocity and depolarization spread in atria |
| GJA5 | Encodes connexin 40, atrial-specific gap junction protein | Variants associated with atrial fibrillation; affects atrial conduction |
| PITX2 | Transcription factor regulating atrial ion channel expression | GWAS locus for atrial fibrillation; modulates depolarization-related genes |
| TBX5 | Transcription factor important for atrial development and ion channel expression | Mutations cause Holt-Oram syndrome with atrial arrhythmias |
| NPPA | Encodes atrial natriuretic peptide, a marker of atrial stretch | Elevated in atrial fibrillation; reflects atrial remodeling |
| MYH6 | Encodes alpha-myosin heavy chain, predominant in atria | Mutations linked to atrial septal defects and arrhythmias |
How Is membrane depolarization during atrial cardiac muscle cell action potential Regulated?
The process of membrane depolarization during atrial cardiac muscle cell action potential is regulated by multiple factors, including autonomic nervous system tone, electrolyte concentrations, and intracellular signaling pathways [3, 8]. Beta-adrenergic stimulation increases sodium and calcium currents, enhancing depolarization, while muscarinic activation reduces them. Mechano-electric feedback provides a dynamic regulation where mechanical stretch modulates ion channel activity. Additionally, microRNAs can directly bind to ion channels and modulate action potential properties, including depolarization. In disease states such as atrial fibrillation, electrical remodeling alters the expression and function of ion channels, leading to changes in depolarization kinetics [1, 8].
membrane depolarization during atrial cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Brugada syndrome, atrial fibrillation, long QT syndrome | Knockout or point-mutation hiPSC-derived atrial cardiomyocytes [1, 6] |
| KCNA5 | Atrial fibrillation, familial atrial standstill | Overexpression or knockout in hiPSC-aCMs to study IKur remodeling [1, 8] |
| PITX2 | Atrial fibrillation susceptibility | Knockout or knock-in in hiPSC-aCMs to assess ion channel expression changes |
| CACNA1C | Timothy syndrome, Brugada syndrome | Point mutation knock-in in hiPSC-aCMs to study calcium current effects [2, 8] |
| GJA5 | Atrial fibrillation, gap junction dysfunction | Knockout in hiPSC-aCMs to evaluate conduction changes |
Atrial Fibrillation and Electrical Remodeling
Atrial fibrillation is characterized by rapid, irregular atrial electrical activity, and electrical remodeling in this condition significantly alters atrial cardiomyocyte depolarization [1, 8]. Studies using human induced pluripotent stem cell-derived atrial cardiomyocytes from patients with atrial fibrillation have shown changes in action potential morphology, including alterations in upstroke velocity and resting potential. These changes are associated with modified expression of ion channels such as SCN5A, CACNA1C, and KCNA5, which directly affect depolarization [1, 8]. Understanding these remodeling processes is crucial for developing targeted therapies that restore normal atrial depolarization.
Mechano-Electric Feedback and Arrhythmias
Mechanical stretch of the atria, as occurs in heart failure or mitral valve disease, can trigger arrhythmias through mechano-electric feedback. Stretch-activated ion channels and cytoskeletal remodeling alter the depolarization phase, promoting ectopic activity and reentry. This mechanism is particularly relevant in atrial fibrillation, where atrial dilation is a common finding. Experimental models that mimic stretch, such as isolated atrial preparations or stretchable substrates for cardiomyocytes, are used to study these effects.
Genetic Channelopathies Affecting Atrial Depolarization
Mutations in genes encoding ion channels, such as SCN5A, can lead to inherited arrhythmia syndromes that affect atrial depolarization [6, 8]. For example, loss-of-function mutations in SCN5A reduce sodium current, slowing atrial depolarization and increasing susceptibility to atrial fibrillation. Similarly, mutations in calcium channel genes can alter the depolarization plateau and predispose to arrhythmias [2, 8]. These channelopathies provide insight into the molecular determinants of atrial depolarization and serve as models for gene editing studies.
From membrane depolarization during atrial cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SCN5A reduce atrial depolarization velocity? | SCN5A knockout hiPSC-derived atrial cardiomyocytes [1, 6] |
| How does a specific SCN5A variant affect sodium current? | Point mutation knock-in hiPSC-aCMs |
| Can overexpression of KCNA5 restore normal repolarization? | KCNA5 overexpression in hiPSC-aCMs [1, 8] |
| What is the role of PITX2 in regulating ion channel genes? | PITX2 knockout or tagged knock-in hiPSC-aCMs |
| Does mechano-electric feedback require specific stretch-activated channels? | Knockout of candidate channels in hiPSC-aCMs under stretch |
| Can CRISPR library screening identify modifiers of atrial depolarization? | Genome-wide CRISPR screen in hiPSC-aCMs with voltage-sensitive dyes |
How to Study the membrane depolarization during atrial cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Action potential parameters and ionic currents | Assessing depolarization in hiPSC-aCMs and native atrial cells [5, 8] |
| Optical mapping | Spatiotemporal propagation of depolarization | Studying conduction and arrhythmias in atrial tissue models |
| Calcium imaging | Intracellular calcium transients | Linking depolarization to calcium handling |
| RNA sequencing | Gene expression profiles | Identifying ion channel remodeling in disease |
| Proteomics | Protein abundance and modifications | Validating ion channel expression changes |
| CRISPR screening | Phenotypic effects of gene knockouts | Discovering novel regulators of atrial depolarization |
| Dynamic clamp | Real-time simulation of ionic conductances | Dissecting contributions of specific currents to depolarization |
| Voltage-sensitive dyes | Membrane potential changes in cell populations | High-throughput screening of drug effects on depolarization |
Patch-Clamp Electrophysiology
Patch-clamp techniques, including whole-cell and perforated patch, are the gold standard for measuring action potentials and ionic currents in atrial cardiomyocytes [5, 8]. These methods allow direct assessment of depolarization parameters such as upstroke velocity, threshold, and peak potential. When combined with dynamic clamp, they can simulate ionic conductances to study their contributions to depolarization. Patch-clamp is often applied to hiPSC-derived atrial cardiomyocytes to validate gene editing outcomes [1, 5].
Optical Mapping and Voltage-Sensitive Dyes
Optical mapping using voltage-sensitive dyes enables non-invasive measurement of action potential propagation and depolarization timing in multicellular preparations. This technique is valuable for studying atrial conduction and arrhythmia mechanisms in engineered heart tissues or monolayers of hiPSC-aCMs. It can reveal spatial heterogeneity in depolarization and the effects of genetic modifications.
Calcium Imaging
Calcium imaging with fluorescent indicators measures intracellular calcium transients that are tightly linked to action potential depolarization. In atrial cardiomyocytes, calcium release from the sarcoplasmic reticulum occurs during the plateau phase, but early calcium entry through L-type channels contributes to depolarization. Combining calcium imaging with electrophysiology provides a comprehensive view of excitation-contraction coupling.
Transcriptomics and Proteomics
RNA sequencing and proteomics can quantify expression levels of ion channels and regulatory proteins in atrial cardiomyocytes [1, 8]. These approaches are used to identify molecular changes underlying electrical remodeling in atrial fibrillation and to validate CRISPR-mediated gene modifications. For example, transcriptomic profiling of hiPSC-aCMs from atrial fibrillation patients revealed altered expression of depolarization-related genes.
How CRISPR Can Be Used to Study GO:0098912 membrane depolarization during atrial cardiac muscle cell action potential
Knockout
CRISPR-Cas9 knockout of genes such as SCN5A or KCNA5 in hiPSC-derived atrial cardiomyocytes allows researchers to determine their essential roles in atrial depolarization [1, 6]. Knockout models can reveal compensatory changes and help validate drug targets. For example, SCN5A knockout reduces sodium current and slows upstroke velocity, mimicking loss-of-function channelopathies.
Point Mutation
Introducing specific point mutations, such as those found in SCN5A variants associated with atrial fibrillation, enables precise modeling of channelopathies. These models are used to study how single amino acid changes affect channel gating, current density, and depolarization kinetics. Point mutation knock-in hiPSC-aCMs provide a human-relevant platform for drug testing.
Knock-in
Knock-in of reporter genes or tags, such as fluorescent proteins fused to ion channels, allows real-time visualization of channel localization and trafficking in atrial cardiomyocytes. Tagged knock-in models can also be used to study protein interactions and post-translational modifications that regulate depolarization.
Overexpression
Overexpression of ion channels or regulatory proteins, such as KCNA5 or PITX2, in hiPSC-aCMs can test gain-of-function effects on atrial depolarization [1, 8]. Overexpression models are useful for studying electrical remodeling and for screening compounds that modulate depolarization.
How EDITGENE Supports membrane depolarization during atrial cardiac muscle cell action potential Research
Researchers studying membrane depolarization during atrial cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in the process or merely a bystander. This requires precise genetic manipulation in relevant cell models, such as hiPSC-derived atrial cardiomyocytes, followed by functional assays like patch-clamp or optical mapping [1, 5]. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for membrane depolarization during atrial cardiac muscle cell action potential research.
Frequently Asked Questions About membrane depolarization during atrial cardiac muscle cell action potential
What is GO:0098912?
GO:0098912 is a Gene Ontology biological process term that describes the membrane depolarization phase of the atrial cardiac muscle cell action potential, where the membrane potential rapidly rises from resting to peak [1, 8].
What genes are involved in membrane depolarization during atrial cardiac muscle cell action potential?
Key genes include SCN5A (NaV1.5), CACNA1C, KCNA5, KCND3, and others encoding ion channels that mediate or modulate the upstroke [6, 8].
How is atrial depolarization different from ventricular depolarization?
Atrial cardiomyocytes express distinct ion channel isoforms, such as KCNA5 (IKur) and GJA5 (connexin 40), which shape a shorter action potential and different depolarization kinetics compared to ventricular cells [1, 8].
What diseases are associated with abnormal atrial depolarization?
Atrial fibrillation, Brugada syndrome, long QT syndrome, and other supraventricular arrhythmias are linked to altered atrial depolarization [1, 3, 6, 8].
What research models are used to study atrial depolarization?
Human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCMs), animal models, and heterologous expression systems are commonly used [1, 5].
How can CRISPR help study atrial depolarization?
CRISPR knockout, point mutation, knock-in, and overexpression in hiPSC-aCMs allow causal testing of genes involved in atrial depolarization [1, 5, 6].
What is the role of SCN5A in atrial depolarization?
SCN5A encodes NaV1.5, the primary sodium channel responsible for the rapid upstroke of the atrial action potential [6, 8].
Can microRNAs regulate atrial depolarization?
Yes, microRNAs can directly bind to ion channels and modulate action potential properties, including depolarization.
What is mechano-electric feedback in the atria?
Mechano-electric feedback is the modulation of cardiac electrical activity by mechanical stretch, which can alter atrial depolarization and contribute to arrhythmias.
How does atrial fibrillation affect depolarization?
Atrial fibrillation causes electrical remodeling that alters ion channel expression and function, leading to changes in depolarization velocity and action potential morphology [1, 8].
Conclusion
GO:0098912, membrane depolarization during atrial cardiac muscle cell action potential, is a fundamental process in cardiac electrophysiology that underlies normal atrial function and is disrupted in common arrhythmias such as atrial fibrillation [1, 8]. Advances in hiPSC-based models and CRISPR gene editing have enabled precise dissection of the ion channels and regulatory pathways involved [1, 5, 6]. Continued research into this process promises to yield new therapeutic strategies for atrial arrhythmias and improve patient outcomes.
References
- 1. Seibertz F et al.. 2023. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.. Cardiovasc Res 119(16):2623-2637 PMID: 37677054
- 2. Blatter LA et al.. 2021. Excitation-contraction coupling and calcium release in atrial muscle.. Pflugers Arch 473(3):317-329 PMID: 33398498
- 3. Ravens U. 2003. Mechano-electric feedback and arrhythmias.. Prog Biophys Mol Biol 82(1-3):255-66 PMID: 12732284
- 4. Yang D et al.. 2021. MicroRNA Biophysically Modulates Cardiac Action Potential by Direct Binding to Ion Channel.. Circulation 143(16):1597-1613 PMID: 33590773
- 5. Verkerk AO et al.. 2021. Dynamic Clamp in Electrophysiological Studies on Stem Cell-Derived Cardiomyocytes-Why and How?. J Cardiovasc Pharmacol 77(3):267-279 PMID: 33229908
- 6. Shy D et al.. 2013. Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model.. Biochim Biophys Acta 1833(4):886-94 PMID: 23123192
- 8. Grandi E et al.. 2011. Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation.. Circ Res 109(9):1055-66 PMID: 21921263
